THE ANTIBIOTIC
GAMBLE
Paratek Pharmaceuticals made a life-saving drug and
got it approved. So why is the company’s long-term
survival still in question? By Maryn McKenna
Evan Loh, chief executive of the US firm Paratek Pharmaceuticals, leads a team that is striving to secure the future of a new antibiotic.
HANNAH YOON FORNATURE338 | Nature | Vol 584 | 20 August 2020
Feature
©
2020
Springer
Nature
Limited.
All
rights
reserved. ©
2020
Springer
Nature
Limited.
All
rights
reserved.